BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:04 PM
 | 
Jul 28, 2009
 |  BC Extra  |  Company News

FDA posts Saphris briefing documents

FDA briefing documents released ahead of a Thursday meeting of the Psychopharmacologic Drugs Advisory Committee indicate the agency is confident that Saphris asenapine from Schering-Plough Corp. (NYSE:SGP) is safe...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >